Patents by Inventor SOLÈNE E. BOITARD

SOLÈNE E. BOITARD has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11345658
    Abstract: The present invention relates to compounds, to compositions comprising the same, to methods for preparing the compounds, and the use of these compounds in therapy. In particular, the present invention relates to a compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.
    Type: Grant
    Filed: March 11, 2020
    Date of Patent: May 31, 2022
    Assignees: QUANTUM GENOMICS, INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, COLLEGE DE FRANCE
    Inventors: Fabrice Balavoine, Delphine Compere, Mathilde Keck, Yannick Marc, Catherine Llorens-Cortes, Solène E. Boitard
  • Publication number: 20220041548
    Abstract: The present invention relates to compounds, to compositions comprising the same, to methods for preparing the compounds, and the use of these compounds in therapy. In particular, the present invention relates to a compound that is useful in the treatment and prevention of primary and secondary arterial hypertension, ictus, myocardial ischaemia, cardiac and renal insufficiency, myocardial infarction, peripheral vascular disease, diabetic proteinuria, Syndrome X and glaucoma.
    Type: Application
    Filed: March 11, 2020
    Publication date: February 10, 2022
    Inventors: FABRICE BALAVOINE, DELPHINE COMPERE, MATHILDE KECK, YANNICK MARC, CATHERINE LLORENS-CORTES, SOLÈNE E. BOITARD